In this current network meta-analysis, we evaluated 23 CVOTs, including the most recently published trials AMPLITUDE-O and EMPEROR-P
GLP-1 medications such as Wegovy, Ozempic, and Zepbound have become increasingly popular for treating obesity and Type 2 diabetes, but insurance coverage for these medications remains inconsistent and financially challenging for consumers who have resorted to getting their GLP1s through other avenues
34 The trial had a total of 731 patients with a baseline mean A1C of 8.2% and a baseline total daily dose of insulin ranging from 56 to 62 units, depending on the treatment group
41 men and 74 women)
Some TrimRx and Ro customers have reported friction during cancellation, so it's worth reviewing each platform's current cancellation policy before signing up
How it works: As you eat, metabolic processes are triggered in your body